These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 21559771)
21. Association of NKG2A with treatment for chronic hepatitis C virus infection. Harrison RJ; Ettorre A; Little AM; Khakoo SI Clin Exp Immunol; 2010 Aug; 161(2):306-14. PubMed ID: 20550548 [TBL] [Abstract][Full Text] [Related]
22. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection. Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004 [TBL] [Abstract][Full Text] [Related]
23. IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56 Dubois S; Conlon KC; Müller JR; Hsu-Albert J; Beltran N; Bryant BR; Waldmann TA Cancer Immunol Res; 2017 Oct; 5(10):929-938. PubMed ID: 28842470 [TBL] [Abstract][Full Text] [Related]
24. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859 [TBL] [Abstract][Full Text] [Related]
26. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56 Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS Front Immunol; 2020; 11():1231. PubMed ID: 32625211 [TBL] [Abstract][Full Text] [Related]
27. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda. Naluyima P; Eller MA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Sandberg JK AIDS; 2014 Jun; 28(9):1273-8. PubMed ID: 24959961 [TBL] [Abstract][Full Text] [Related]
28. CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection. Lin AW; Gonzalez SA; Cunningham-Rundles S; Dorante G; Marshall S; Tignor A; Ha C; Jacobson IM; Talal AH Clin Exp Immunol; 2004 Aug; 137(2):408-16. PubMed ID: 15270860 [TBL] [Abstract][Full Text] [Related]
29. Increased Peripheral NKG2A-NKG2D+CD3-CD16+CD56dim NK Cell Subset Was Positively Correlated with Antiphospholipid Antibodies in Patients of Obstetric Antiphospholipid Syndrome. Zhang Y; Zhao Y; Si W; Yang B; Lin M; Zheng J; Cui L Immunol Invest; 2022 Feb; 51(2):425-437. PubMed ID: 33103514 [TBL] [Abstract][Full Text] [Related]
30. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus. Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119 [TBL] [Abstract][Full Text] [Related]
31. Participation of the CD94 receptor complex in costimulation of human natural killer cells. Voss SD; Daley J; Ritz J; Robertson MJ J Immunol; 1998 Feb; 160(4):1618-26. PubMed ID: 9469418 [TBL] [Abstract][Full Text] [Related]
33. CD56 Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139 [TBL] [Abstract][Full Text] [Related]
34. In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells. Mukherjee S; Jensen H; Stewart W; Stewart D; Ray WC; Chen SY; Nolan GP; Lanier LL; Das J Sci Signal; 2017 Jun; 10(485):. PubMed ID: 28655861 [TBL] [Abstract][Full Text] [Related]
35. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363 [TBL] [Abstract][Full Text] [Related]
36. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499 [TBL] [Abstract][Full Text] [Related]
37. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development. Domaica CI; Fuertes MB; Uriarte I; Girart MV; Sardañons J; Comas DI; Di Giovanni D; Gaillard MI; Bezrodnik L; Zwirner NW PLoS One; 2012; 7(12):e51677. PubMed ID: 23240056 [TBL] [Abstract][Full Text] [Related]